For each committee you’ll find contact details, panels, members and their relevant awards.
Recently funded awards
This page features a selection of awards we have supported at recent committee meetings.
Select a funding committee below to see what they have funded recently:
- Clinical Trials Awards and Advisory Committee
- New Agents Committee
- Population Research Committee
- Science Committee
- Tobacco Advisory Group
- Training and Career Development Board
Phase III Clinical Trials Grants
Mr Christopher Halloran, University of Liverpool
Project title: PANasta - Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy – a double blinded multi-centred trial
Mr John Tidy, University College London
Project title: SHAPE: A randomised phase III trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low-risk early-stage cervical cancer
Sample Collection Grants
Dr Richard Bryan, Dr Alison Birtle, Dr Jane Steele and Dr James Catto University of Birmingham
Project title: The collection of biospecimens from patients eligible for the "POUT" clinical trial in upper urinary tract urothelial carcinoma
Endorsement Late Phase Study
Professor Anthony Chalmers, University of Glasgow
Project title: PARADIGM: Olaparib and radiotherapy in newly-diagnosed glioblastoma.
Professor Gordon Jayson and Professor Gordon Rustin, University of Manchester
Project title: PAZOFOS: A dose escalation phase 1b running into a randomised Phase II Trial of fosbretabulin (a vascular disrupting agent) combined with pazopanib (an anti-angiogenic agent) in the treatment of patients with relapsed ovarian cancer.
Dr Paul Nathan, University of Liverpool
Project title: SELPAC: A Randomised 3-arm Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxol in advanced uveal melanoma.
NAC Preclinical Grants
Dr Stephen Beers University of Southampton
Project title: Combining TLR agonists with LOB7/4 anti-CD40 mAb (ChiLob) in neuroblastoma and lymphoma.
Professor Duncan Jodrell University of Cambridge
Project title: Preclinical combination studies with AZD2014 (mTORi) and Olaparib.
Professor Tim Maughan University of Oxford
Project title: RHYTHM-2: modulation of Radiotherapy according to HYpoxia: exploiting changes in the Tumour Microenvironment to improve outcome in rectal cancer using PF-05212384.
Dr Anderson Ryan University of Oxford
Project title: Combined ATR (AZD6738) and PARP inhibition (olaparib) as therapeutic strategy for TP53 mutated non-small cell lung cancer (NSCLC).
Professor Gillian Tozer University of Sheffield
Project title: Antibody-based VEGF receptor 2 inhibition (DC101) in combination with radiotherapy: influence of VEGF isoforms and related microenvironmental factors.
NAC Trial Grants
Professor Jeffry Evans University of Glasgow
Project title: CRUKD/14/008 PIONEER A Phase I trial of olaparib in combination with chemo-radiation in locally advanced pancreatic cancer.
Dr Martin Forster University College London
Project title: CRUKD/14/011 ORCA2: A phase I trial of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC).
Professor Kevin Harrington Institute of Cancer Research
Project title: CRUKD/14/007 The PATRIOT study: A Phase I trial of the ATR inhibitor AZD6738 alone and in combination with palliative radiotherapy.
Professor David Walker University of Nottingham
Project title: CRUKD/14/002 INTREPID: A Phase I trial of continuous intrathecal/intraventricular infusion of Etoposide, investigating dose escalation and duration of infusion in children and adolescents with leptomeningeal metastases of solid tumours (jointly funded by The Brain Tumour Charity).
Dr Timothy Yap Institute of Cancer Research
Project title: CRUKD/14/004 ComPAKT: A Phase I multi-centre trial of the combination of AZD5363 (AKT inhibitor) and olaparib (PARP inhibitor) in patients with advanced solid tumours.
NAC Trial Endorsements
Dr Udai Banerji Institute of Cancer Research
Project title: CRUKDE/14/009 CombAT HER2: A Phase I trial of the combination of AUY922 (HSP90 inhibitor) and lapatinib in patients with HER-2 amplified metastatic breast cancer.
Dr Peter Schmid Barts Cancer Institute & Professor Gary Middleton University of Birmingham
Project title: CRUKDE/14/010 TORCMEK A Phase Ib/IIa trial of AZD2014 in combination with selumetinib in patients with advanced Non-Small-Cell Lung Cancer.
Professor Doug Altman, University of Oxford
Project title: Medical Statistics Group.
Professor Wendy Atkin, Imperial College London
Project title: Screening, prevention and diagnosis of colorectal cancer
Professor Dame Valerie Beral, University of Oxford
Project title: Cancer Epidemiology Unit
Professor Jack Cuzick Queen Mary, University of London
Project title: Cancer Prevention
Professor Sir Richard Peto and Professor Sir Rory Collins, University of Oxford
Project title: Clinical Trial Service Unit and Epidemiological Studies Unit
Professor Peter Sasieni Queen Mary, University of London
Project title: Cancer Screening and Statistics
Professor Peter Sasieni Queen Mary, University of London
Project title: Cancer Prevention Trials Unit (CPTU)
Professor Andrew Biankin, University of Glasgow
Project title: Advancing genotype guided stratified therapy for pancreatic cancer
Professor Keith Caldecott, University of Sussex
Project title: Non-homologous end-joining protein complexes and genome stability
Professor Tim Elliott and Dr Edward James University of Southampton
Project title: Peptide selection in the MHC I antigen processing pathway and its relevance to cancer
Dr Phil Jones, University of Cambridge
Project title: Clonal evolution in oesophageal squamous preneoplasia
Professor Tony Kouzarides, University of Cambridge
Project title: Function of chromatin modifications and their role in cancer
Professsor Kenneth Young, The Royal Surrey County Hospital
Project title: OPTIMAM2: Optimisation of breast cancer detection using digital X-ray technology
Biomarker Project Grants
Dr Emma King and Professor Gareth Thomas, University of Southampton
Project title: Immune response evaluation as a prognostic tool in HPV-positive oropharyngeal cancer
Professor Kathy Pritchard-Jones, Institute of Child Health and University College London
Project title: A biomarker approach to improving population outcomes for renal tumours of childhood
Drug Discovery Project Grants
Professor John Atack, University of Sussex
Project title: Identification of phosphatase specific inhibitors of the DNA damage repair enzyme polynucleotide kinase 3´ phosphatase (PNKP) via a dual fragment and virtual screening approach
Professor Peter Fischer, University of Nottingham
Project title: Development of selective CDK9-cyclin T1 pharmacological inhibitors for the treatment of chronic lymphocytic leukaemia
Dr Robert Gilbert, University of Oxford
Project title: Identifying small-molecule inhibitors of cancer-related cytoplasmic uridylyltransferase activities controlling tumour-suppressor miRNA biogenesis
Dr Martin Pule, University College London
Project title: Exploration of CD160 targeting
Ms Deborah Arnott, Action on Smoking and Health
Project title: Planning for the Endgame: Sustaining the momentum of tobacco control in a new era: reflecting on progress since the publication of Beyond Smoking Kills and defining a new national tobacco control agenda for 2015-2020
Mrs Florence Berteletti-Kemp, Smoke Free Partnership
Project title: Smoke Free Partnership 2014-16
Dr Marisa de Andrade, University of Stirling
Project title: Marketing of e-cigarettes
Miss Elen de Lacy, Action on Smoking and Health (Wales)
Project title: ASH Wales: Tackling the illicit tobacco market in Wales
Dr Elena Ratschen, University of Nottingham
Project title: Treating smoking in mental health inpatient settings – exploring options to implement new NICE guidance
Ms Emily Robinson, Alcohol Concern
Project title: Health First Advocacy Project
Research Travel Awards
Dr Maya Ghoussaini, University of Cambridge, travelling to Queensland - Australia
Project title: Functional characterisation of the candidate causal variants at the 9p21 breast cancer susceptibility locus
Dr Nadia Hegarat, University of Sussex, travelling to Munich - Germany
Project title: Characterization of chromatin-binding properties of kinesins using Fluorescence Correlation Spectroscopy
Dr Helen Matthews, University College London, travelling to Paris - France
Project title: Environmental control of cancer cell division
Dr Danielle Park, Cancer Research UK London Research Institute, travelling to Barcelona - Spain
Project title: Understanding the biophysical forces modulating strand-like invasion in invasive lobular carcinoma
Dr Samantha Warren, University of Oxford, travelling to Switzerland
Project title: Optimising x-ray and proton radiotherapy treatment plans for thoracic or abdominal tumours: trade-offs in plan quality and plan robustness and possibilities for dose escalation and normal tissue sparing
Conference and Meetings Awards
Dr Ester Hammond, Gray Institute for Radiation Oncology and Biology
Association for Radiation Research Meeting - at the University of Sussex
Professor Herbie Newell, University of Newcastle
Imaging in Stratified Cancer Treatment – methodology, preclinical discovery and clinical trials - at the University of Newcastle
Professor Len Seymour, University of Oxford
8th International Conference on Oncolytic Virus Therapeutics - at the University of Oxford
Professor Jane Wardle, University College London
9th UKSBM Annual Scientific Meeting - Behavioural Medicine: From Laboratory to Policy - at the University of Oxford